Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml
Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml is a medicine authorised by Swissmedic under authorisation number 62719. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 November 2013 and the authorisation is valid without a time limit. ATC code M05BA06 places the medicine in the group Drugs for treatment of bone diseases.
| Authorisation number | 62719 |
|---|---|
| Name | Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml |
| Full name | Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M05BA06 |
| First authorisation | 20 November 2013 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml, Injektionslösung in einer Fertigspritze | B | 20 November 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | M05BA06 | 07.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml authorised in Switzerland?
Yes. Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml is authorised by Swissmedic under authorisation number 62719, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml have?
Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ibandronat-Mepha Osteo i.v. 3 mg/ 3 ml?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.